ALTURiX acquires exclusive UK rights to three new products
The new products are in the areas of gastrointestinal and respiratory medicines
Read More
Tag: ALTURiX
ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
